OCUGEN INC. DL-,001 |
USA |
Gesundheit |
US67577C1053 / A2PSZH |
2H51 (Frankfurt) / OCGN (NASDAQ) |
FRA:2H51, ETR:2H51, 2H51:GR, NASDAQ:OCGN |
- |
https://ocugen.com/ |
Ocugen Inc. is a biopharmaceutical company focused..
>Volltext.. |
272.61 Mio. EUR |
277.54 Mio. EUR |
4.07 Mio. EUR |
-44.79 Mio. EUR |
-48.73 Mio. EUR |
-0.17 EUR |
28.09 Mio. EUR |
23.12 Mio. EUR |
-44.26 Mio. EUR |
1.5 |
21.29% |
1.08% |
- |
- |
- |
- |
OCUGEN |
31.08.25 |
|
||||
|
||||
|